It’s been a tough time for almost every industry because of the pandemic. However, it seems that medtech is rising above these challenges.
Deal activity has increased and more companies seem to be going public. EY’s annual Pulse of the Industry Report highlights these trends and touches on the rise of Special Purpose Acquisition Company (SPAC) mergers.
Jim Welch, EY’s Global MedTech leader, Health Sciences and Wellness division, stops by the Let’s Talk Medtech podcast to break through these trends and discuss what they mean for the industry.